Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.
Gastrointestinal Neuroendocrine Tumours
Survey on the clinical utility of the QLQ-GINET21, which the investigator is to complete for each patient enrolled, Day 1
Socio-demographic variables of the investigator, Descriptive analysis of socio-demographic variables including age, gender, years of experience in treating neuroendocrine tumours (NETs), area of professional activity, capacity of the hospital, Day 1|Socio-demographic variables of the patient, Descriptive analysis of socio-demographic variables including age, gender, employment status, marital status, educational level, Day 1|Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-GINET21, Day 1|Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-C30, Day 1|Clinical characteristics of patients - time since first therapeutic intervention, Day 1|Health status as perceived by the patient, Patients assess their overall health status in relation to their gastrointestinal neuroendocrine tumour, with a question designed for this purpose: "Please answer the question by marking the response that best defines your current health status as related to your neuroendocrine disease". The response options are: Very good, quite good, somewhat good, neither good nor bad, somewhat bad, quite bad, very bad., Day 1|Clinical assessment of patient's health status by the investigator, The investigator evaluates the patient's health status in relation to the gastrointestinal neuroendocrine tumour by answering the following question: Overall, how would you rate the patient's health status in relation to their gastrointestinal neuroendocrine tumour as of today? The response options are: Very good, quite good, somewhat good, neither good nor bad, somewhat bad, quite bad, very bad., Day 1
The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.